Summit Therapeutics Inc. (SMMT)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch SMMT
See up to 3 months of SMMT. The 7-day demo opens the 1M and 3M ranges and puts SMMT on your watchlist.
Start 7-day demoLatest SMMT insider trades
- Mahkam Zanganeh - OfficerOpen-market purchase$49.99M
Robert W. Duggan - OfficerOpen-market purchase$49.99M- Robert W. Duggan - OfficerOpen-market purchase$1.46M
- Mahkam Zanganeh - OfficerOpen-market purchase$1.46M
- Manmeet Singh Soni - OfficerOpen-market purchase$362K
- Manmeet Singh Soni - OfficerOpen-market purchase$361K
- Yu Xia - DirectorOpen-market purchase$10.00M
- Mahkam Zanganeh - OfficerOpen-market purchase$500K
About Summit Therapeutics Inc. (SMMT)
Summit Therapeutics Inc. is an SEC registrant, filing under CIK 0001599298, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
SMMT Form 4 activity by transaction type, last 90 days
No Form 4 activity for SMMT in the last 90 days.
SMMT insider transactions (Form 4)
3018 Form 4 filings on record, the earliest from Oct 3, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mahkam Zanganeh - Officer | Open-market purchase | Common Stock | 3,810,000 | $13.12 | $49.99M | |
| Robert W. Duggan - Officer | Open-market purchase | Common Stock | 3,810,000 | $13.12 | $49.99M | |
| Robert W. Duggan - Officer | Open-market purchase | Common Stock | 100,000 | $14.60 | $1.46M | |
| Mahkam Zanganeh - Officer | Open-market purchase | Common Stock | 100,000 | $14.60 | $1.46M | |
| Manmeet Singh Soni - Officer | Open-market purchase | Common Stock | 25,000 | $14.46 | $362K | |
| Manmeet Singh Soni - Officer | Open-market purchase | Common Stock | 25,000 | $14.43 | $361K | |
| Yu Xia - Director | Open-market purchase | Common Stock | 533,617 footnote F1 | $18.74 | $10.00M | |
| ||||||
| Bhaskar Anand - Officer | Grant or award | Common Stock | 26,680 footnote F1 | $18.74 | $500K | |
| ||||||
| Manmeet Singh Soni - Officer | Grant or award | Common Stock | 53,361 footnote F1 | $18.74 | $1.00M | |
| ||||||
| Mahkam Zanganeh - Officer | Grant or award | Common Stock | 13,980,789 footnote F1 | $18.74 | $262.00M | |
| Mahkam Zanganeh - Officer | Grant or award | Common Stock | 266,808 footnote F1 | $18.74 | $5.00M | |
| Mahkam Zanganeh - Officer | Open-market purchase | Common Stock | 26,680 footnote F1 | $18.74 | $500K | |
| ||||||
| Robert W. Duggan - Officer | Grant or award | Common Stock | 13,980,789 footnote F1 | $18.74 | $262.00M | |
| Robert W. Duggan - Officer | Grant or award | Common Stock | 266,808 footnote F1 | $18.74 | $5.00M | |
| Robert W. Duggan - Officer | Open-market purchase | Common Stock | 26,680 footnote F1 | $18.74 | $500K | |
| ||||||
| Bhaskar Anand - Officer | Grant or award | Stock Option (right to buy) | 50,000 | - | - | |
| Mahkam Zanganeh - Officer | Open-market purchase | Common Stock | 333,394 | $17.68 | $5.89M | |
| Mahkam Zanganeh - Officer | Open-market purchase | Common Stock | 5,000 | $18.07 | $90K | |
| Robert W. Duggan - Officer | Open-market purchase | Common Stock | 333,394 | $17.68 | $5.89M | |
| Robert W. Duggan - Officer | Open-market purchase | Common Stock | 5,000 | $18.07 | $90K | |
| Robert W. Duggan - Officer | Option exercise | Common Stock | 74,545 | $2.64 | $197K | |
| Robert W. Duggan - Officer | Option exercise | Stock Option (right to buy) | 74,545 | $0.00 | - | |
| Robert W. Duggan - Officer | Grant or award | Stock Option (right to buy) | 1,040,000 | - | - | |
| Robert W. Duggan - Officer | Grant or award | Stock Option (right to buy) | 400,000 | - | - | |
| Robert W. Duggan - Officer | Grant or award | Stock Option (right to buy) | 9,590,558 | - | - | |
| Robert W. Duggan - Officer | Other | Common Stock | 3,985,055 | $1.58 | $6.30M | |
| Robert W. Duggan - Officer | Other | Warrant (right to buy) | 3,985,055 | $0.00 | - | |
| Kenneth A. Clark - Director | Grant or award | Stock Option (right to buy) | 200,000 | - | - | |
| Mahkam Zanganeh - Officer | Other | Common Stock | 315,681 | $1.58 | $499K | |
| Mahkam Zanganeh - Officer | Other | Warrant (right to buy) | 315,681 | $0.00 | - | |
Item 1.01, 3.02, 5.03, 8.01, 9.01
Item 8.01, 9.01
Item 8.01, 9.01
Item 8.01, 9.01
Item 8.01, 9.01
SMMT insider trading FAQ
What is the latest insider trade for SMMT?
Summit Therapeutics Inc. (SMMT) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-12. The full record for SMMT runs to 18 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SMMT stock?
No insider purchases of SMMT were filed in the last 90 days. 13 purchases are on record for this company.
How many insiders are selling SMMT stock?
No insider sales of SMMT were filed in the last 90 days.
Where can I see SMMT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SMMT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Mahkam Zanganeh view on EDGAR
- - Robert W. Duggan view on EDGAR
- - Robert W. Duggan view on EDGAR
- - Mahkam Zanganeh view on EDGAR
- - Manmeet Singh Soni view on EDGAR
- - Yu Xia view on EDGAR
- - Bhaskar Anand view on EDGAR
- - Manmeet Singh Soni view on EDGAR
- - Mahkam Zanganeh view on EDGAR
- - Robert W. Duggan view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where SMMT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SMMT with a 7-day demo
- SMMT on your watchlist
- Every SMMT Form 4 filing on record
- Up to 3 months of SMMT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.